PacWest Financial Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$28.9M Buy
25,098
+221
+0.9% +$25.5K 1.71% 16
2016
Q3
$2.94M Sell
24,877
-1,869
-7% -$227K 1.8% 13
2016
Q2
$3.24M Sell
26,746
-3,137
-10% -$356K 2.03% 11
2016
Q1
$3.23M Sell
29,883
-1,068
-3% -$111K 2.08% 12
2015
Q4
$3.18M Sell
30,951
-245
-0.8% -$24.6K 2.13% 9
2015
Q3
$2.91M Sell
31,196
-1,131
-3% -$109K 2.15% 8
2015
Q2
$3.15M Buy
32,327
+350
+1% +$35K 2.22% 8
2015
Q1
$3.22M Buy
31,977
+447
+1% +$45.5K 2.27% 8
2014
Q4
$3.3M Buy
31,530
+6,983
+28% +$736K 2.34% 6
2014
Q3
$2.62M Buy
24,547
+290
+1% +$30.1K 1.94% 12
2014
Q2
$2.54M Sell
24,257
-1,055
-4% -$107K 1.88% 13
2014
Q1
$2.49M Buy
25,312
+305
+1% +$28.3K 1.93% 11
2013
Q4
$2.29K Sell
25,007
-300
-1% -$27.6K 0.69% 16
2013
Q3
$2.19M Buy
25,307
+420
+2% +$37.7K 1.89% 13
2013
Q2
$2.14M Buy
+24,887
New +$2.11M 2.03% 11

Other funds holding JNJ

PacWest Financial Management's JNJ Position: Q4 2016 in Review

PacWest Financial Management increased its Johnson & Johnson (JNJ) stake by 0.89% in Q4 2016, buying an estimated $25.5K and bringing the position to 25,098 shares worth $28.9M. The position accounts for 1.71% of the portfolio, ranked #16.

PacWest Financial Management first reported a position in JNJ in Q2 2013 and has held it in 15 quarters since. 2,321 funds tracked by Wall St. Rank hold JNJ as of Q4 2016.

  • PacWest Financial Management held 25,098 shares of Johnson & Johnson worth $28.9M as of Q4 2016.
  • PacWest Financial Management bought 221 Johnson & Johnson shares in Q4 2016, an estimated $25.5K.
  • Johnson & Johnson made up 1.71% of PacWest Financial Management's portfolio in Q4 2016, its #16 holding.
  • PacWest Financial Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 15 quarters since.
  • 2,321 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.